Piper Sandler adjusted its outlook on Keros Therapeutics (NASDAQ:KROS), significantly reducing the price target from $40.00 ...

The report highlighted that while the company's vision and team are strong, the resolution of existing overhangs might require more time than anticipated. As a result, Piper Sandler advocates for a ...

In a report released today, Anna Andreeva from Piper Sandler maintained a Hold rating on Lululemon Athletica (LULU – Research Report), with a ...

In a report released today, David Amsellem from Piper Sandler reiterated a Hold rating on Biogen (BIIB – Research Report), with a price target ...

On Monday, Jan. 7, Michael Lavery at Piper Sandler initiated coverage of the beverage giant, with an overweight rating and a ...

Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of John Kerins as a ...

Piper Sandler Companies is gaining traction with a recovering market. Find out why PIPR stock is becoming an attractive ...

UnitedHealth (UNH) stock and CVS Health (CVS) stock were named top picks at Piper Sandler on a potential hike in Medicare payments next year. Read more here.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Piper Sandler raised the firm’s price target on Arhaus (ARHS) to $15 from $14 and keeps an Overweight rating on the shares ...

Piper Sandler estimates that AI/HPC data center contracts could potentially triple miner EBITDA at certain sites. The note ...

Despite recent share appreciation, Piper Sandler believes there is still significant upside for Kenvue. “Though shares have ...